Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Mihail Celeski"'
Autor:
Giuseppe Di Gioia, Armando Ferrera, Mihail Celeski, Raffaella Mistrulli, Erika Lemme, Federica Mango, Maria Rosaria Squeo, Antonio Pelliccia
Publikováno v:
Life, Vol 14, Iss 11, p 1452 (2024)
Introduction: Metabolic syndrome (MS) is a growing global public health concern that is associated with increased risk for cardiovascular events, even in athletes. The lipid accumulation product (LAP) index and cardiometabolic index (CMI) have been s
Externí odkaz:
https://doaj.org/article/7372688b905041369a81f301c76fdaef
Autor:
Mihail Celeski, Andrea Segreti, Mariagrazia Piscione, Luigi Maria Monticelli, Giuseppe Di Gioia, Chiara Fossati, Gian Paolo Ussia, Fabio Pigozzi, Francesco Grigioni
Publikováno v:
Monaldi Archives for Chest Disease (2024)
Although it is known that exercise improves cardiovascular health and extends life expectancy, a significant number of people may also experience an elevation in cardiac troponin levels as a result of exercise. For many years, researchers have argued
Externí odkaz:
https://doaj.org/article/13c0db5198744ddca7f9decb39f5a65e
Autor:
Mihail Celeski, Annunziata Nusca, Valeria Maria De Luca, Giorgio Antonelli, Valeria Cammalleri, Rosetta Melfi, Fabio Mangiacapra, Elisabetta Ricottini, Paolo Gallo, Nino Cocco, Raffaele Rinaldi, Francesco Grigioni, Gian Paolo Ussia
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 2, p 39 (2024)
Takotsubo syndrome (TTS) is a clinical condition characterized by temporary regional wall motion anomalies and dysfunction that extend beyond a single epicardial vascular distribution. Various pathophysiological mechanisms, including inflammation, mi
Externí odkaz:
https://doaj.org/article/96fcd83a72474f14bb733a911e43e9da
Autor:
Federico Bernardini, Martina Gelfusa, Mihail Celeski, Federica Coletti, Annunziata Nusca, Domenico De Stefano, Francesco Piccirillo, Fabio Mangiacapra, Paolo Gallo, Valeria Cammalleri, Nino Cocco, Raffaele Rinaldi, Carlo Cosimo Quattrocchi, Gian Paolo Ussia, Francesco Grigioni
Publikováno v:
Applied Sciences, Vol 13, Iss 1, p 241 (2022)
Coronary artery disease (CAD) still represents a leading cause of mortality worldwide. Early identification of patients at the highest risk of CAD is crucial to prevent acute adverse events and reduce morbidity and mortality. The coronary artery calc
Externí odkaz:
https://doaj.org/article/709e6ff446454daea51b39d0ccf44ce2
Autor:
Flavio Giuseppe Biccirè, Gaetano Tanzilli, Francesco Prati, Emanuele Sammartini, Martina Gelfusa, Mihail Celeski, Simone Budassi, Francesco Barillà, Gregory Y.H. Lip, Daniele Pastori
Publikováno v:
International Journal of Cardiology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b856555f5ddfebc64878060aefe506c
https://doi.org/10.1016/j.ijcard.2023.05.023
https://doi.org/10.1016/j.ijcard.2023.05.023
Autor:
Martina Gelfusa, Flavio Giuseppe Biccirè, Gaetano Tanzilli, Francesco Prati, Emanuele Sammartini, Mihail Celeski, Simone Budassi, Francesco Barillà, Gregory Y H Lip, Daniele Pastori
Publikováno v:
European Heart Journal Supplements. 24
Aims New onset atrial fibrillation (NOAF) is associated with worse clinical outcomes after acute coronary syndrome (ACS). Identification of patients at risk of NOAF remains challenging, and various clinical scores of varying complexities have been pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c007422673fd60b7684747b19c7eecad
https://doi.org/10.1093/eurheartjsupp/suac121.515
https://doi.org/10.1093/eurheartjsupp/suac121.515
Autor:
Mihail Celeski, Flavio Giuseppe Biccirè, Laura Gatto, Gian Paolo Ussia, Francesco Grigioni, Francesco Prati
Publikováno v:
European Heart Journal Supplements. 24
Background It is now well-acknowledged that patients with overt COVID-19 are at increased risk of a broad range of acute cardiovascular disorders including myocardial infarction, myocarditis, pericarditis, pulmonary embolism, vasculitis and thromboem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adab095205bfc9d4759a18b407e11732
https://doi.org/10.1093/eurheartjsupp/suac121.027
https://doi.org/10.1093/eurheartjsupp/suac121.027
Autor:
Mihail Celeski, Miriam Compagnone, Nevio Taglieri, Gabriele Ghetti, Cinzia Marrozzini, Mateusz Orzalkiewicz, Antonio Giulio Bruno, Nazzareno Galiè, Francesco Saia, Tullio Palmerini
Publikováno v:
European Heart Journal Supplements. 24
Background Percutaneous coronary intervention (PCI) appears a reasonable alternative to coronary artery bypass graft in selected groups of patients with unprotected left main coronary artery (ULMCA) disease. Despite technological progression, improve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45b66094c768ef82cb06cb70030ae74c
https://doi.org/10.1093/eurheartjsupp/suac121.312
https://doi.org/10.1093/eurheartjsupp/suac121.312
Autor:
Andrea Segreti, Mihail Celeski, Luigi Maria Monticelli, Alfonso Perillo, Simone Pasquale Crispino, Giuseppe Di Gioia, Valeria Cammalleri, Chiara Fossati, Simona Mega, Rocco Papalia, Fabio Pigozzi, Gian Paolo Ussia, Francesco Grigioni
Publikováno v:
Journal of Clinical Medicine. 12:3562
Observing mitral or tricuspid valve disease in an athlete raises many considerations for the clinician. Initially, the etiology must be clarified, with causes differing depending on whether the athlete is young or a master. Notably, vigorous training
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ae5eb3505fa8935aa980c45827ad6c7
https://doi.org/10.3390/jcm12103562
https://doi.org/10.3390/jcm12103562
Autor:
Francesco Saia, Mihail Celeski, Mateusz Orzalkiewicz, Antonio Bruno, Nazzareno Galiè, Nevio Taglieri, Cinzia Marrozzini, Miriam Compagnone, Elena Nardi, Tullio Palmerini, Gabriele Ghetti, Maria Letizia Bacchi Reggiani
Publikováno v:
The American Journal of Cardiology. 128:94-100
This study sought to investigate the impact of elective, uncomplicated target lesion revascularization (TLR) on long-term cardiac mortality after percutaneous coronary intervention (PCI) of unprotected left main coronary artery (ULMCA) disease. Conse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05557b08360c133343351885124aeaec
https://doi.org/10.1016/j.amjcard.2020.04.053
https://doi.org/10.1016/j.amjcard.2020.04.053